Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feasibility RCT of Oral Sodium Bicarbonate in Haemodialysis Patients
2015-001439-20Phase 4Completed
- Sponsor
- Imperial College Healthcare NHS Trust
- Start
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of sodium bicarbonate in end-stage kidney disease (ESKD) and metabolic acidosis (2 arms), sponsored by Imperial College Healthcare NHS Trust. Primary endpoints: Pre-dialysis blood potassium level and Intradialytic potassium gradient. Started Aug 2015; status: completed.
02
Drugs
sodium bicarbonate
03
Conditions
end-stage kidney disease (ESKD)metabolic acidosis
Beyond the preview
Go deeper on 2015-001439-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001439-20.